Category: Labor
Poster Session III
338 women were induced for hypertensive diseases: 284 (84%) with PgE2 and 54 (16%) with CRB; 477 women were induced for diabetes: 383 (80.3%) with PgE2 and 94 (19.7%) with CRB; and 539 were induced for prolonged pregnancy: 436 (81.3%) with pgE2 and 103 (18.7%) with CRB. As shown in table 1, there were no significant differences in baseline maternal or labor characteristics, except for lower oxytocin augmentation rate in the PgE2 group (p < 0.05).
Time interval from induction to delivery was statistically significant only when the indication for induction was prolonged pregnancy, being shorter by using PgE2 for induction (24.1 vs. 29.3 hours, p< 0.05). The neonatal intensive care unit admission rate was significantly lower in the PgE2 compared with the CRB induction group only when the indication for induction was maternal hypertensive disease (5% vs. 15%, p< 0.05). No other significant differences were found.
Conclusion: In our population we found an advantage of using PgE2 for labor induction in patients induced for prolonged pregnancy, in terms of shorter time interval from induction to delivery.
Gal Bachar, MD (she/her/hers)
Rambam Healthcare Campus
Haifa, Israel
Amir Wolfovitz, MD (he/him/his)
Rambam Medical Center
Haifa, Israel
Hiba Abu-Rass, MD
Rambam Medical Health Campus
Haifa, Israel, Israel
Yousef Abboud, MD, PhD
Rambam Medical Health Campus
Haifa, Israel, Israel
Ron Beloosesky, MD
Rambam Medical Health Campus
Haifa, Israel, Israel
Dana Vitner, MD
Rambam Health Care Campus
Nadier GHANIM, MD
Rambam Health Care Campus
Haifa, Israel, Israel
Yuval Ginsberg, MD (he/him/his)
Deputy Ob/Gyn department
Rambam Medical Health Campus
Haifa, Israel
Yaniv Zipori, MD
Rambam Healthcare Campus
Binyamina, HaZafon, Israel
Zeev Weiner, MD
Rambam Health Care Campus
Haifa, Israel, Israel
Nizar Khatib, MD
Rambam Healthcare Campus
Acre, Hefa, Israel